Rapid Assessment Drug Adherence Report (RADARSM) with Graphed Results
Millennium Laboratories sets industry standards in testing and reporting. Our leading-edge technology and proprietary methodologies produce rapid turnaround of comprehensive, quantified test results, generally within one day of specimen receipt at our lab.
RADAR provides a snapshot of comprehensive test results, helping to reconcile consistencies and inconsistencies with medications reported on the test requisition. Our optional graphed results allow the health care professional to visualize and easily understand and compare patient results with Millennium average levels and historical results from the patient’s previous tests.
Benefits of Graphed Results
- The Comparative Results graph assists health care professionals with determining whether the patient’s result is consistent with or similar to those of other patients prescribed and taking the same medication, unrelated to dosage.
- The Historical Results graph provides a quick reference guide for comparing a single patient’s urine drug testing (UDT) results over time.
- Both graphs quickly identify atypical results or those that are inconsistent with typical UDT results for the named medication.
Additional benefits of our report include custom comments regarding specific drugs/metabolites and their detection windows, a full list of tabulated results, and specimen validity levels and reference ranges. Test results can be received by fax, online or secure email for your convenience.
Our customers have access to our toxicologists and pharmacologists who are available for live results discussion every day.
RADAR Hotline 866-866-0605
Monday through Friday, 5:00 a.m.– 9:00 p.m. Pacific Time
Saturday and Sunday, 7:00 a.m. – 3:30 p.m. Pacific Time
We offer quarterly Practice Profiles, a full results summary of submitted specimens and a comparison of results-to-results from nationwide samples submitted to Millennium during that same period. These profiles summarize expected and unexpected results, positive test results and in-office false positive and false negative results. These data are compiled and shared in easily read charts with custom comments from clinical review.
Reviewing practice data over time, analyzing benefits and limitations of in-office testing, and comparing results to the national average may help health care professionals assess and reconcile their prescribing patterns and support their drug testing protocols.